These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16275085)

  • 1. Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors.
    Xiang JS; Hu Y; Rush TS; Thomason JR; Ipek M; Sum PE; Abrous L; Sabatini JJ; Georgiadis K; Reifenberg E; Majumdar M; Morris EA; Tam S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):311-6. PubMed ID: 16275085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.
    Hu Y; Xing L; Thomason JR; Xiang J; Ipek M; Guler S; Li H; Sabatini J; Chockalingam P; Reifenberg E; Sheldon R; Morris EA; Georgiadis KE; Tam S
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6800-3. PubMed ID: 21982494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.
    Hopper DW; Vera MD; How D; Sabatini J; Xiang JS; Ipek M; Thomason J; Hu Y; Feyfant E; Wang Q; Georgiadis KE; Reifenberg E; Sheldon RT; Keohan CC; Majumdar MK; Morris EA; Skotnicki J; Sum PE
    Bioorg Med Chem Lett; 2009 May; 19(9):2487-91. PubMed ID: 19329309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
    Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
    Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.
    De Savi C; Pape A; Sawyer Y; Milne D; Davies C; Cumming JG; Ting A; Lamont S; Smith PD; Tart J; Page K; Moore P
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3301-6. PubMed ID: 21536437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.
    Durham TB; Klimkowski VJ; Rito CJ; Marimuthu J; Toth JL; Liu C; Durbin JD; Stout SL; Adams L; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR
    J Med Chem; 2014 Dec; 57(24):10476-85. PubMed ID: 25415648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
    Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
    Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of aggrecanase and MMP in cartilage degradation].
    Ishiguro N; Kojima T
    Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
    Roughley PJ; Barnett J; Zuo F; Mort JS
    Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
    Hu Y; Xiang JS; DiGrandi MJ; Du X; Ipek M; Laakso LM; Li J; Li W; Rush TS; Schmid J; Skotnicki JS; Tam S; Thomason JR; Wang Q; Levin JI
    Bioorg Med Chem; 2005 Dec; 13(24):6629-44. PubMed ID: 16216515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.
    Takizawa M; Yatabe T; Okada A; Chijiiwa M; Mochizuki S; Ghosh P; Okada Y
    FEBS Lett; 2008 Aug; 582(19):2945-9. PubMed ID: 18671975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?
    Huang K; Wu LD
    Mol Biol Rep; 2010 Mar; 37(3):1241-5. PubMed ID: 19277895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of aggrecanase activity by tetracyclines and proteoglycan loss from osteoarthritic human articular cartilage.
    Steinmeyer J; Kordelle J; Stürz H
    J Orthop Res; 2010 Jun; 28(6):828-33. PubMed ID: 20069635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis.
    Dancevic CM; McCulloch DR
    Arthritis Res Ther; 2014; 16(5):429. PubMed ID: 25606593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microplate assay for the screening of ADAMTS-4 inhibitors.
    Thomas M; Sabatini M; Bensaude F; Mignard B; Ortuno JC; Caron I; Boutin JA; Ferry G
    Matrix Biol; 2006 May; 25(4):261-7. PubMed ID: 16442274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro.
    Moulharat N; Lesur C; Thomas M; Rolland-Valognes G; Pastoureau P; Anract P; De Ceuninck F; Sabatini M
    Osteoarthritis Cartilage; 2004 Apr; 12(4):296-305. PubMed ID: 15023381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational approaches to improve aggrecanase-1 inhibitory activity of (4-keto) phenoxy) methyl biphenyl-4-sulfonamide: group based QSAR and docking studies.
    Sivakumar PM; Selvaraj NV; Ramesh G; Mohanapriya J; Prabhawathi V; Doble M
    Med Chem; 2012 Jul; 8(4):673-82. PubMed ID: 22548335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.